104
Participants
Start Date
March 21, 2022
Primary Completion Date
January 2, 2024
Study Completion Date
January 2, 2024
chiglitazar sodium tablets
the drugs will be given orally once a day
Placebo
no active drug contained
Beijing Friendship Hospital, Capital Medical University, Beijing
Beijing Youan Hospital, Capital Medical University, Beijing
Peking University People's Hospital, Beijing
The First Hospital of Lanzhou University, Lanzhou
Foshan First People's Hospital, Foshan
The First Affiliated Hospital of Sun Yat-sen University, Guangzhou
Henan Provincial People's Hospital, Zhengzhou
The First Affiliated Hospital of Anhui Medical University, Hefei
Nanjing Second Hospital, Nanjing
The First Hospital of Jilin University, Ch’ang-ch’un
The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an
Shanghai Tongren Hospital, Shanghai
The Ninth People's Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai
Affiliated Hospital of Hangzhou Normal University, Hangzhou
First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou
Lead Sponsor
Chipscreen Biosciences, Ltd.
INDUSTRY